measuregroup/AID1148541

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242644380_AID1148541_PMID690997_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103277492_AID1148541_PMID690997_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242644382_AID1148541_PMID690997_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242644379_AID1148541_PMID690997_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103169867_AID1148541_PMID690997_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1088
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Drug level in po dosed human urine treated with lidocaine
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103169867 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242644380 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242644382 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103277492 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242644379
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1148541

Total number of triples: 15.